1. Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice‐weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone. Issue 6 (19th March 2021) Authors: Korde, Neha; Mastey, Donna; Tavitian, Elizabet; Mailankody, Sham; Lesokhin, Alexander; Hassoun, Hani; Smith, Eric L.; Lendvai, Nikoletta; Hultcrantz, Malin; Shah, Urvi; Tan, Carlyn; Lu, Sydney; Diamond, Benjamin; Salcedo, Meghan; Werner, Kelly; Chung, David J.; Scordo, Michael; Shah, Gunjan L.; L... Journal: American journal of hematology Issue: Volume 96:Issue 6(2021) Page Start: E193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ixazomib and dexamethasone in high risk smoldering multiple myeloma: a clinical and correlative pilot study. Issue 11 (19th September 2022) Authors: Mailankody, Sham; Salcedo, Meghan; Tavitian, Elizabet; Burge, Miranda; Korde, Neha; Hassoun, Hani; Lesokhin, Alexander; Lahoud, Oscar; Smith, Eric; Hultcrantz, Malin; Tan, Carlyn; Shah, Urvi; Devlin, Sean; Landgren, Ola Journal: Leukemia & lymphoma Issue: Volume 63:Issue 11(2022) Page Start: 2760 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis. (15th August 2021) Authors: Piedra, Katrina; Peterson, Tim; Tan, Carlyn; Orozco, Jennifer; Hultcrantz, Malin; Hassoun, Hani; Mailankody, Sham; Lesokhin, Alexander; Shah, Urvi; Lu, Sydney; Patel, Dhwani; Derkach, Andriy; Wilkins, Cy R.; Korde, Neha Journal: British journal of haematology Issue: Volume 196:Number 1(2022) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi‐institutional experience. Issue 7 (2nd May 2022) Authors: Mohan, Meera; Becnel, Melody Renee; Shah, Urvi A.; Dong, Huaying; Gundarlapalli, Sravani; Peterson, Timothy; Orozco, Jennifer S.; Horowitz, Sandra; Chhabra, Saurabh; Dhakal, Binod; Thanendrarajan, Sharmilan; Radhakrishnan, Sabarinath Venniyil; Al Hadidi, Samer; Tan, Carlyn; Mailankody, Sham; Hult... Journal: American journal of hematology Issue: Volume 97:Issue 7(2022) Page Start: E276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial. Issue 6 (June 2021) Authors: Diamond, Benjamin; Korde, Neha; Lesokhin, Alexander M; Smith, Eric L; Shah, Urvi; Mailankody, Sham; Hultcrantz, Malin; Hassoun, Hani; Lu, Sydney X; Tan, Carlyn; Rustad, Even H; Maura, Francesco; Maclachlan, Kylee; Peterson, Tim; Derkach, Andriy; Devlin, Sean; Landau, Heather J; Scordo, Michael; C... Journal: Lancet Issue: Volume 8:Issue 6(2021) Page Start: e422 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: Emphasizing the need for a consensus approach. Issue 3 (1st January 2023) Authors: Pianko, Matthew J.; Tiutan, Timothy; Derkach, Andriy; Flynn, Jessica; Salvatore, Steven P.; Jaffer‐Sathick, Insara; Rossi, Adriana C.; Lahoud, Oscar; Hultcrantz, Malin; Shah, Urvi A.; Maclachlan, Kylee; Chung, David J.; Shah, Gunjan L.; Landau, Heather J.; Korde, Neha; Mailankody, Sham; Lesokhin,... Journal: American journal of hematology Issue: Volume 98:Issue 3(2023) Page Start: 421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy. Issue 14 (6th December 2022) Authors: Nath, Karthik; Shekarkhand, Tala; Salcedo, Meghan; Derkach, Andriy; Rueda, Siobhan; Chansakul, Aisara; Hulcrantz, Malin; Korde, Neha; Shah, Urvi A.; Tan, Carlyn; Chung, David J.; Lahoud, Oscar B.; Hassoun, Hani; Lesokhin, Alexander M.; Landau, Heather J.; Shah, Gunjan; Scordo, Michael; Giralt, Se... Journal: Leukemia & lymphoma Issue: Volume 63:Issue 14(2022) Page Start: 3488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗